MARKET

MRNA

MRNA

Moderna
NASDAQ
29.49
-0.92
-3.03%
After Hours: 29.48 -0.01 -0.03% 19:59 12/31 EST
OPEN
30.26
PREV CLOSE
30.41
HIGH
30.39
LOW
29.06
VOLUME
8.95M
TURNOVER
--
52 WEEK HIGH
48.92
52 WEEK LOW
22.28
MARKET CAP
11.52B
P/E (TTM)
-3.6639
1D
5D
1M
3M
1Y
5Y
1D
Moderna Inc. Stock Sheds 3.0%, Underperforms Peers
Dow Jones · 12/31/2025 21:32
BUZZ-Vaccine makers end the year in red
Reuters · 12/31/2025 11:44
Moderna Inc. Stock Slips 2.4%, Underperforms Peers
Dow Jones · 12/30/2025 21:34
Notable Tuesday Option Activity: LLY, CRWD, MRNA
NASDAQ · 12/30/2025 19:19
Mixed options sentiment in Moderna with shares down 0.64%
TipRanks · 12/30/2025 18:45
1 Mooning Stock to Own for Decades and 2 We Find Risky
Barchart · 12/30/2025 08:40
Noteworthy ETF Inflows: XBI, FOLD, MRNA, EXEL
NASDAQ · 12/29/2025 15:59
Weekly Report: what happened at MRNA last week (1222-1226)?
Weekly Report · 12/29/2025 09:45
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.